TGFβ2 can promote the expression of CREB1 in tumor cells23 and CD44 is a classic marker of breast cancer stem cells.17 We wanted to know whether SRGN can regulate CD44 TGFβ2 protein expression and CREB1 phosphorylation. Here, CD44 is linked to breast carcinoma.